▶ 調査レポート

口腔がん治療の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Oral Cancer Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。口腔がん治療の世界市場 2020年:企業別、地域別、種類・用途別 / Global Oral Cancer Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-16296資料のイメージです。• レポートコード:D0804-16296
• 出版社/出版日:GlobalInfoResearch / 2020年7月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥372,360 (USD3,480)▷ お問い合わせ
  Multi User¥558,540 (USD5,220)▷ お問い合わせ
  Corporate User¥744,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、口腔がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。口腔がん治療の種類別市場規模(標的療法、化学療法)、用途別市場規模(口腔がん床、ガムがん、硬口蓋がん、内頬がん(頬粘膜がん)、口唇がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):AstraZeneca Plc、Pfizer Inc.、Endo International Plc、Bristol-Myers Squibb Co.、Mylan NV、Eli Lilly and Co.、Teva Pharmaceutical Industries Ltd.、Merck & Co., Inc.、F. Hoffmann-La Roche Ltd.、Sanofi
・地域別グローバル市場分析 2015年-2020年
・口腔がん治療の北米市場(アメリカ、カナダ、メキシコ)
・口腔がん治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・口腔がん治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・口腔がん治療の南米市場(ブラジル、アルゼンチン)
・口腔がん治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:標的療法、化学療法
・用途別分析:口腔がん床、ガムがん、硬口蓋がん、内頬がん(頬粘膜がん)、口唇がん、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Oral Cancer Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Oral Cancer Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Oral Cancer Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oral Cancer Therapeutic market has been segmented into:
Targeted Therapy
Chemotherapy

By Application, Oral Cancer Therapeutic has been segmented into:
Floor of Mouth Cancer
Gum Cancer
Hard Palate Cancer
Inner Cheek Cancer (Buccal Mucosa Cancer)
Lip Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Cancer Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Cancer Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Cancer Therapeutic market.

The report offers in-depth assessment of the growth and other aspects of the Oral Cancer Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Oral Cancer Therapeutic Market Share Analysis
Oral Cancer Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Cancer Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Cancer Therapeutic sales, revenue and market share for each player covered in this report.

The major players covered in Oral Cancer Therapeutic are:
AstraZeneca Plc
Pfizer Inc.
Endo International Plc
Bristol-Myers Squibb Co.
Mylan NV
Eli Lilly and Co.
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Sanofi

レポート目次

Table of Contents

1 Oral Cancer Therapeutic Market Overview
1.1 Product Overview and Scope of Oral Cancer Therapeutic
1.2 Classification of Oral Cancer Therapeutic by Type
1.2.1 Global Oral Cancer Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oral Cancer Therapeutic Revenue Market Share by Type in 2019
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.3 Global Oral Cancer Therapeutic Market by Application
1.3.1 Overview: Global Oral Cancer Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Floor of Mouth Cancer
1.3.3 Gum Cancer
1.3.4 Hard Palate Cancer
1.3.5 Inner Cheek Cancer (Buccal Mucosa Cancer)
1.3.6 Lip Cancer
1.3.7 Others
1.4 Global Oral Cancer Therapeutic Market by Regions
1.4.1 Global Oral Cancer Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oral Cancer Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oral Cancer Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oral Cancer Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oral Cancer Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oral Cancer Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oral Cancer Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc. SWOT Analysis
2.2.4 Pfizer Inc. Product and Services
2.2.5 Pfizer Inc. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Endo International Plc
2.3.1 Endo International Plc Details
2.3.2 Endo International Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Endo International Plc SWOT Analysis
2.3.4 Endo International Plc Product and Services
2.3.5 Endo International Plc Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb Co.
2.4.1 Bristol-Myers Squibb Co. Details
2.4.2 Bristol-Myers Squibb Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb Co. SWOT Analysis
2.4.4 Bristol-Myers Squibb Co. Product and Services
2.4.5 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan NV
2.5.1 Mylan NV Details
2.5.2 Mylan NV Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan NV SWOT Analysis
2.5.4 Mylan NV Product and Services
2.5.5 Mylan NV Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly and Co.
2.6.1 Eli Lilly and Co. Details
2.6.2 Eli Lilly and Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly and Co. SWOT Analysis
2.6.4 Eli Lilly and Co. Product and Services
2.6.5 Eli Lilly and Co. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Teva Pharmaceutical Industries Ltd. Details
2.7.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.7.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.7.5 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck & Co., Inc.
2.8.1 Merck & Co., Inc. Details
2.8.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck & Co., Inc. SWOT Analysis
2.8.4 Merck & Co., Inc. Product and Services
2.8.5 Merck & Co., Inc. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche Ltd.
2.9.1 F. Hoffmann-La Roche Ltd. Details
2.9.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.9.4 F. Hoffmann-La Roche Ltd. Product and Services
2.9.5 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Oral Cancer Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oral Cancer Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oral Cancer Therapeutic Players Market Share
3.2.2 Top 10 Oral Cancer Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oral Cancer Therapeutic Revenue and Market Share by Regions
4.2 North America Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Oral Cancer Therapeutic Revenue by Countries
5.1 North America Oral Cancer Therapeutic Revenue by Countries (2015-2020)
5.2 USA Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Oral Cancer Therapeutic Revenue by Countries
6.1 Europe Oral Cancer Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oral Cancer Therapeutic Revenue by Countries
7.1 Asia-Pacific Oral Cancer Therapeutic Revenue by Countries (2015-2020)
7.2 China Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Oral Cancer Therapeutic Revenue by Countries
8.1 South America Oral Cancer Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oral Cancer Therapeutic by Countries
9.1 Middle East & Africa Oral Cancer Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oral Cancer Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Oral Cancer Therapeutic Market Forecast by Type (2019-2024)
10.3 Targeted Therapy Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
11 Global Oral Cancer Therapeutic Market Segment by Application
11.1 Global Oral Cancer Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Oral Cancer Therapeutic Market Forecast by Application (2019-2024)
11.3 Floor of Mouth Cancer Revenue Growth (2015-2020)
11.4 Gum Cancer Revenue Growth (2015-2020)
11.5 Hard Palate Cancer Revenue Growth (2015-2020)
11.6 Inner Cheek Cancer (Buccal Mucosa Cancer) Revenue Growth (2015-2020)
11.7 Lip Cancer Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Oral Cancer Therapeutic Market Size Forecast (2021-2025)
12.1 Global Oral Cancer Therapeutic Market Size Forecast (2021-2025)
12.2 Global Oral Cancer Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Oral Cancer Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Cancer Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Cancer Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oral Cancer Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Plc Corporate Information, Location and Competitors
Table 6. AstraZeneca Plc Oral Cancer Therapeutic Major Business
Table 7. AstraZeneca Plc Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca Plc SWOT Analysis
Table 9. AstraZeneca Plc Oral Cancer Therapeutic Product and Solutions
Table 10. AstraZeneca Plc Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Inc. Corporate Information, Location and Competitors
Table 12. Pfizer Inc. Oral Cancer Therapeutic Major Business
Table 13. Pfizer Inc. Oral Cancer Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer Inc. SWOT Analysis
Table 15. Pfizer Inc. Oral Cancer Therapeutic Product and Solutions
Table 16. Pfizer Inc. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Endo International Plc Corporate Information, Location and Competitors
Table 18. Endo International Plc Oral Cancer Therapeutic Major Business
Table 19. Endo International Plc Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. Endo International Plc SWOT Analysis
Table 21. Endo International Plc Oral Cancer Therapeutic Product and Solutions
Table 22. Endo International Plc Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol-Myers Squibb Co. Corporate Information, Location and Competitors
Table 24. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Major Business
Table 25. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. Bristol-Myers Squibb Co. SWOT Analysis
Table 27. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Product and Solutions
Table 28. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Mylan NV Corporate Information, Location and Competitors
Table 30. Mylan NV Oral Cancer Therapeutic Major Business
Table 31. Mylan NV Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Mylan NV SWOT Analysis
Table 33. Mylan NV Oral Cancer Therapeutic Product and Solutions
Table 34. Mylan NV Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly and Co. Corporate Information, Location and Competitors
Table 36. Eli Lilly and Co. Oral Cancer Therapeutic Major Business
Table 37. Eli Lilly and Co. Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly and Co. SWOT Analysis
Table 39. Eli Lilly and Co. Oral Cancer Therapeutic Product and Solutions
Table 40. Eli Lilly and Co. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 42. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Major Business
Table 43. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 45. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Product and Solutions
Table 46. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 48. Merck & Co., Inc. Oral Cancer Therapeutic Major Business
Table 49. Merck & Co., Inc. Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Merck & Co., Inc. SWOT Analysis
Table 51. Merck & Co., Inc. Oral Cancer Therapeutic Product and Solutions
Table 52. Merck & Co., Inc. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 54. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Major Business
Table 55. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 57. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Product and Solutions
Table 58. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sanofi Corporate Information, Location and Competitors
Table 60. Sanofi Oral Cancer Therapeutic Major Business
Table 61. Sanofi Oral Cancer Therapeutic Total Revenue (USD Million) (2017-2018)
Table 62. Sanofi SWOT Analysis
Table 63. Sanofi Oral Cancer Therapeutic Product and Solutions
Table 64. Sanofi Oral Cancer Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Oral Cancer Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 66. Global Oral Cancer Therapeutic Revenue Share by Players (2015-2020)
Table 67. Global Oral Cancer Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Oral Cancer Therapeutic Revenue Market Share by Regions (2015-2020)
Table 69. North America Oral Cancer Therapeutic Revenue by Countries (2015-2020)
Table 70. North America Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Table 71. Europe Oral Cancer Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Oral Cancer Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Oral Cancer Therapeutic Revenue by Countries (2015-2020)
Table 74. South America Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Oral Cancer Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Table 77. Global Oral Cancer Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 78. Global Oral Cancer Therapeutic Revenue Share by Type (2015-2020)
Table 79. Global Oral Cancer Therapeutic Revenue Forecast by Type (2021-2025)
Table 80. Global Oral Cancer Therapeutic Revenue by Application (2015-2020)
Table 81. Global Oral Cancer Therapeutic Revenue Share by Application (2015-2020)
Table 82. Global Oral Cancer Therapeutic Revenue Forecast by Application (2021-2025)
Table 83. Global Oral Cancer Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oral Cancer Therapeutic Picture
Figure 2. Global Oral Cancer Therapeutic Revenue Market Share by Type in 2019
Figure 3. Targeted Therapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Oral Cancer Therapeutic Revenue Market Share by Application in 2019
Figure 6. Floor of Mouth Cancer Picture
Figure 7. Gum Cancer Picture
Figure 8. Hard Palate Cancer Picture
Figure 9. Inner Cheek Cancer (Buccal Mucosa Cancer) Picture
Figure 10. Lip Cancer Picture
Figure 11. Others Picture
Figure 12. Global Oral Cancer Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Oral Cancer Therapeutic Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Oral Cancer Therapeutic Revenue Market Share in 2019
Figure 21. Global Top 10 Players Oral Cancer Therapeutic Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Oral Cancer Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 25. Global Oral Cancer Therapeutic Revenue Market Share by Regions in 2018
Figure 26. North America Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Europe Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. South America Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. North America Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 32. North America Oral Cancer Therapeutic Revenue Market Share by Countries in 2019
Figure 33. USA Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 34. Canada Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. Europe Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Oral Cancer Therapeutic Revenue Market Share by Countries in 2019
Figure 38. Germany Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. UK Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. France Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. Russia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Italy Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Oral Cancer Therapeutic Revenue Market Share by Countries in 2019
Figure 45. China Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Japan Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. Korea Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. India Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. South America Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 51. South America Oral Cancer Therapeutic Revenue Market Share by Countries in 2019
Figure 52. Brazil Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Oral Cancer Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Oral Cancer Therapeutic Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. UAE Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Oral Cancer Therapeutic Revenue and Growth Rate (2015-2020)
Figure 60. Global Oral Cancer Therapeutic Revenue Share by Type (2015-2020)
Figure 61. Global Oral Cancer Therapeutic Revenue Share by Type in 2019
Figure 62. Global Oral Cancer Therapeutic Market Share Forecast by Type (2021-2025)
Figure 63. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Oral Cancer Therapeutic Revenue Share by Application (2015-2020)
Figure 66. Global Oral Cancer Therapeutic Revenue Share by Application in 2019
Figure 67. Global Oral Cancer Therapeutic Market Share Forecast by Application (2021-2025)
Figure 68. Global Floor of Mouth Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Gum Cancer Revenue Growth Rate (2015-2020)
Figure 70. Global Hard Palate Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Inner Cheek Cancer (Buccal Mucosa Cancer) Revenue Growth Rate (2015-2020)
Figure 72. Global Lip Cancer Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Oral Cancer Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Oral Cancer Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Oral Cancer Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
Figure 78. Europe Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. South America Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Oral Cancer Therapeutic Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel